Sullivan Christopher Ryan - Insider Non-Derivative Transactions at Avalo Therapeutics, Inc. (AVTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 9, 2023, Sullivan Christopher Ryan's relationship to Avalo Therapeutics, Inc. (AVTX) is Officer (Chief Financial Officer), and currently has 1,262 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AVTX insiders.
Data Source: SEC.
Sullivan Christopher Ryan - Insider Non-Derivative Transactions at AVTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 10, 2023 | P -- (Common Stock) | 511 | 3.42 | 1262 |